Literature DB >> 28608255

Temporal trends in herpes zoster-related hospitalizations in Italy, 2001-2013: differences between regions that have or have not implemented varicella vaccination.

Nicoletta Valente1, Silvia Cocchio2, Armando Stefanati1, Tatjana Baldovin2, Domenico Martinelli3, Rosa Prato3, Vincenzo Baldo2, Giovanni Gabutti4.   

Abstract

BACKGROUND: Herpes zoster (HZ) has a relevant impact on the population in terms of incidence and complications. AIMS: The aim of this study was to estimate the HZ-related hospitalization rates in Italy in the period 2001-2013, and to evaluate the trend of hospitalizations in the course of time pointing out any differences between regions that have or have not introduced universal childhood varicella immunization (UVI).
METHODS: A retrospective analysis was conducted on hospital discharge records contained in the national database of the Ministry of Health for the period January 2001-December 2013. The comparison of hospitalization rates of "pilot" versus "not pilot" regions was performed taking into account as "pilot" regions the three that first introduced UVI (Sicily, Veneto, and Apulia). The average annual percentage change in hospitalization rates was used to highlight any significant change in time trends.
RESULTS: In the period 2001-2013, 93,808 HZ-related hospitalizations were registered altogether. Complicated HZ was diagnosed in 53.2% of cases; a relevant part (32.5%) of hospitalizations involved subjects with at least one co-morbidity. In the three Italian "pilot" regions, a greater decrease of HZ-related hospitalization rates occurred in comparison to other regions. DISCUSSION: A good understanding of the epidemiology of HZ disease is required to assess the overall impact of the varicella immunization programs and to establish the most appropriate health strategies against HZ.
CONCLUSIONS: The data obtained confirm the epidemiological impact of HZ and its complications and the need of a preventive approach.

Entities:  

Keywords:  Herpes zoster; Hospitalizations; Temporal trends; Varicella vaccination

Mesh:

Substances:

Year:  2017        PMID: 28608255     DOI: 10.1007/s40520-017-0782-z

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  4 in total

Review 1.  A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile.

Authors:  Federica Brosio; Giulia Masetti; Giulio Matteo; Armando Stefanati; Giovanni Gabutti
Journal:  Infect Drug Resist       Date:  2018-09-05       Impact factor: 4.003

2.  The Unknown Health Burden of Herpes Zoster Hospitalizations: The Effect on Chronic Disease Course in Adult Patients ≥50 Years.

Authors:  Maria Francesca Piazza; Chiara Paganino; Daniela Amicizia; Cecilia Trucchi; Andrea Orsi; Matteo Astengo; Paolo Romairone; Simona Simonetti; Giancarlo Icardi; Filippo Ansaldi
Journal:  Vaccines (Basel)       Date:  2020-01-10

3.  Clinical characteristics of hospitalized adults and adolescents with herpes zoster in Croatia: more than 20 years of a single-center experience.

Authors:  Dalibor Vukelić; Dorotea Oroši Končić; Jelena Prepolec; Iva Škrabić; Andrea Šupe Parun; Tomislava Skuhala; Vladimir Trkulja
Journal:  Croat Med J       Date:  2020-10-31       Impact factor: 1.351

4.  Herpes zoster epidemiology in Latin America: A systematic review and meta-analysis.

Authors:  Ariel Esteban Bardach; Carolina Palermo; Tomás Alconada; Macarena Sandoval; Darío Javier Balan; Javier Nieto Guevara; Jorge Gómez; Agustin Ciapponi
Journal:  PLoS One       Date:  2021-08-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.